Patents by Inventor Astrid Markus-Erb

Astrid Markus-Erb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-Phenylbenzofuran derivatives, a process for preparing them, and their use
    Patent number: 7148254
    Abstract: The present invention relates to 2-phenylbenzofurans of formula (I) which are formed, during fermentation, by the microorganism Aspergillus flavipes ST003878 (DSM 15290), to a process for preparing them and to their use as pharmaceuticals for the treatment and/or prophylaxis of bacterial infectious diseases or mycoses.
    Type: Grant
    Filed: October 25, 2004
    Date of Patent: December 12, 2006
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Laszlo Vertesy, Michael Kurz, Astrid Markus-Erb, Luigi Toti
  • Hydroxyphenylundecane, a process for their production and their use
    Patent number: 7112608
    Abstract: The present invention relates to novel hydroxyphenylundecane derivatives of the formula (I), a method for the preparation of said compounds by cultivation of the fungus Cryphonectria parasitica, DSM 14453, and their use as pharmaceuticals, i.e. for the treatment of Alzheimer's Disease, Parkinson's Disease, Huntington's Diseases, stroke, psychosis and/or depressions.
    Type: Grant
    Filed: October 1, 2003
    Date of Patent: September 26, 2006
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Cordula Hopmann, Martin Knauf, Mark Brönstrup, Astrid Markus-Erb, Luigi Toti
  • Gabusectin derivatives, processes for preparing them and their use
    Patent number: 6962943
    Abstract: The present invention relates to compounds of the formula (I) which are formed by the microorganism ST 003236 (DSM 14476) during fermentation, to a process for preparing and derivatizing them, to a pharmaceutical which comprises a compound of the formula (I) and to the use thereof for producing a pharmaceutical.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: November 8, 2005
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Matthias Schiell, Martin Knauf, Luigi Toti, Astrid Markus-Erb
  • 2-Phenylbenzofuran derivatives, a process for preparing them, and their use
    Publication number: 20050137254
    Abstract: The present invention relates to 2-phenylbenzofurans of formula (I) which are formed, during fermentation, by the microorganism Aspergillus flavipes ST003878 (DSM 15290), to a process for preparing them and to their use as pharmaceuticals for the treatment and/or prophylaxis of bacterial infectious diseases or mycoses.
    Type: Application
    Filed: October 25, 2004
    Publication date: June 23, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Laszlo Vertesy, Michael Kurz, Astrid Markus-Erb, Luigi Toti
  • Hydroxyphenylundecane, a process for their production and their use
    Publication number: 20040122092
    Abstract: The present invention relates to novel hydroxyphenylundecane derivatives of the formula (I), 1
    Type: Application
    Filed: October 1, 2003
    Publication date: June 24, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Cordula Hopmann, Martin Knauf, Mark Bronstrup, Astrid Markus-Erb, Luigi Toti
  • Gabusectin derivatives, processes for preparing them and their use
    Publication number: 20030187057
    Abstract: The present invention relates to a compound of formula (I) 1
    Type: Application
    Filed: November 8, 2002
    Publication date: October 2, 2003
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Matthias Schiell, Martin Knauf, Luigi Toti, Astrid Markus-Erb
  • Coniosetin and derivatives thereof, process for the preparation and the use thereof
    Patent number: 6599930
    Abstract: The present invention relates to novel active substances (coniosetin and coniosetin derivatives) of the formula I which are produced by the microorganism Coniochaeta ellipsoidea Udagawa (DSM 13856) during fermentation, wherein R, R2, R3, R4, R5, X, X2, X3 and X4 have the meanings stated in the specification, to chemical derivatives of coniosetin, to a process for their preparation and to their use as pharmaceuticals.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: July 29, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Laszlo Vertesy, Martin Knauf, Astrid Markus-Erb, Luigi Toti, Marie-Cecile Raynal-Wetzel, Florence Fassy
  • Coniosetin and derivatives thereof, process for the preparation and the use thereof
    Publication number: 20020137788
    Abstract: The present invention relates to novel active substances (coniosetin and coniosetin derivatives) of the formula I 1
    Type: Application
    Filed: December 6, 2001
    Publication date: September 26, 2002
    Inventors: Laszlo Vertesy, Martin Knauf, Astrid Markus-Erb, Luigi Toti, Marie Cecile Raynal-Wetzel, Florence Fassy